Philip B. Verghese
Affiliations: | Washington University, Saint Louis, St. Louis, MO |
Area:
Lipid metabolism in NeurodegenerationGoogle:
"Philip Verghese"Mean distance: 16.52 (cluster 31)
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Molina-Henry DP, Raman R, Liu A, et al. (2024) Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Ma Q, Zhao Z, Sagare AP, et al. (2024) Correction: Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism. Molecular Neurodegeneration. 19: 27 |
| Meyer MR, Kirmess KM, Eastwood S, et al. (2024) Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Aβ42/40 ratio to identify presence of brain amyloid. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Cook JD, Malik A, Plante DT, et al. (2023) Associations of Sleep Duration and Daytime Sleepiness with Plasma Amyloid Beta and Cognitive Performance in Cognitively Unimpaired, Middle-Aged and Older Adult African Americans. Sleep |
| Fischer B, Van Hulle CA, Langhough R, et al. (2023) Plasma Aβ42/40 and cognitive variability are associated with cognitive function in Black Americans: Findings from the AA-FAIM cohort. Alzheimer's & Dementia (New York, N. Y.). 9: e12414 |
| Fogelman I, West T, Braunstein JB, et al. (2023) Independent study demonstrates amyloid probability score accurately indicates amyloid pathology. Annals of Clinical and Translational Neurology |
| Ma Q, Zhao Z, Sagare AP, et al. (2022) Correction: Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism. Molecular Neurodegeneration. 17: 71 |
| Aschenbrenner AJ, Li Y, Henson RL, et al. (2022) Comparison of plasma and CSF biomarkers in predicting cognitive decline. Annals of Clinical and Translational Neurology |
| Hu Y, Kirmess KM, Meyer MR, et al. (2022) Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment. Jama Network Open. 5: e228392 |
| Kirmess KM, Meyer MR, Holubasch MS, et al. (2021) The PrecivityAD™ Test: Accurate and Reliable LC-MS/MS Assays for Quantifying Plasma Amyloid Beta 40 and 42 and Apolipoprotein E Proteotype for the Assessment of Brain Amyloidosis. Clinica Chimica Acta; International Journal of Clinical Chemistry |